Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unsupervised excitation: GABAergic dysfunctions in Alzheimer’s disease
Eleonora Ambrad Giovannetti, Martin Fuhrmann
Brain Research (2018) Vol. 1707, pp. 216-226
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer’s disease
Sara Hijazi, Tim S. Heistek, Philip Scheltens, et al.
Molecular Psychiatry (2019) Vol. 25, Iss. 12, pp. 3380-3398
Open Access | Times Cited: 166
Neuronal excitation/inhibition imbalance: core element of a translational perspective on Alzheimer pathophysiology
Fernando Maestú, Willem de Haan, Marc Aurel Busche, et al.
Ageing Research Reviews (2021) Vol. 69, pp. 101372-101372
Open Access | Times Cited: 147
GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer’s disease
Joan Jiménez-Baladó, Teal S. Eich
Seminars in Cell and Developmental Biology (2021) Vol. 116, pp. 146-159
Open Access | Times Cited: 128
Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer’s Disease
Grzegorz A. Czapski, Joanna B. Strosznajder
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11677-11677
Open Access | Times Cited: 106
Alzheimer’s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression
S. Meftah, Jian Gan
Frontiers in Synaptic Neuroscience (2023) Vol. 15
Open Access | Times Cited: 70
Fast-spiking parvalbumin-positive interneurons in brain physiology and Alzheimer’s disease
Sara Hijazi, August B. Smit, Ronald E. van Kesteren
Molecular Psychiatry (2023) Vol. 28, Iss. 12, pp. 4954-4967
Open Access | Times Cited: 46
Sleep disorders cause Parkinson's disease or the reverse is true: Good GABA good night
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ali K. Albuhadily, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 16
Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study
Uma V. Mahajan, Vijay R. Varma, Michael Griswold, et al.
PLoS Medicine (2020) Vol. 17, Iss. 1, pp. e1003012-e1003012
Open Access | Times Cited: 135
Neural oscillations and brain stimulation in Alzheimer’s disease
Zahra Jafari, Bryan Kolb, Majid H. Mohajerani
Progress in Neurobiology (2020) Vol. 194, pp. 101878-101878
Closed Access | Times Cited: 133
The regulation of glutamic acid decarboxylases in GABA neurotransmission in the brain
Seong Eun Lee, Yunjong Lee, Gum Hwa Lee
Archives of Pharmacal Research (2019) Vol. 42, Iss. 12, pp. 1031-1039
Closed Access | Times Cited: 117
Microglial priming of antigen presentation and adaptive stimulation in Alzheimer’s disease
Rashmi Ranjan Das, Subashchandrabose Chinnathambi
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 19, pp. 3681-3694
Closed Access | Times Cited: 104
Neurobiology and Therapeutic Potential of α5-GABA Type A Receptors
Tija C. Jacob
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 95
A multiscale brain network model links Alzheimer’s disease-mediated neuronal hyperactivity to large-scale oscillatory slowing
Anne M van Nifterick, Alida A. Gouw, Ronald E. van Kesteren, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 51
Cortical excitability and plasticity in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis of transcranial magnetic stimulation studies
Ying‐hui Chou, Mark Sundman, Viet Ton That, et al.
Ageing Research Reviews (2022) Vol. 79, pp. 101660-101660
Open Access | Times Cited: 48
The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders
Margrethe A. Olesen, Francisca Villavicencio-Tejo, Rodrigo A. Quintanilla
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 38
The GABAergic system in Alzheimer’s disease: a systematic review with meta-analysis
Giovanna Carello‐Collar, Bruna Bellaver, Pâmela C.L. Ferreira, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 12, pp. 5025-5036
Closed Access | Times Cited: 31
Parvalbumin Interneuron Dysfunction in Neurological Disorders: Focus on Epilepsy and Alzheimer’s Disease
Beulah Leitch
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5549-5549
Open Access | Times Cited: 8
Distinct disease‐sensitive GABAergic neurons in the perirhinal cortex of Alzheimer's mice and patients
Elisabeth Sánchez‐Mejías, Cristina Nuñez‐Diaz, Raquel Sánchez‐Varo, et al.
Brain Pathology (2019) Vol. 30, Iss. 2, pp. 345-363
Open Access | Times Cited: 62
Hippocampal hyperactivity in a rat model of Alzheimer’s disease
Liudmila Sosulina, Manuel Mittag, Hans‐Rüdiger Geis, et al.
Journal of Neurochemistry (2021) Vol. 157, Iss. 6, pp. 2128-2144
Open Access | Times Cited: 44
Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer’s disease
Christopher D. Morrone, Aaron Y. Lai, Jossana Bishay, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Tau in cerebrospinal fluid induces neuronal hyperexcitability and alters hippocampal theta oscillations
Jessica Brown, Elena Camporesi, Juan Lantero Rodrı́guez, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 16
Somatostatin and the pathophysiology of Alzheimer’s disease
Victor N. Almeida
Ageing Research Reviews (2024) Vol. 96, pp. 102270-102270
Closed Access | Times Cited: 7
Araticum (Annona crassiflora Mart.) as a source of nutrients and bioactive compounds for food and non-food purposes: A comprehensive review
Henrique Silvano Arruda, Gláucia María Pastore
Food Research International (2019) Vol. 123, pp. 450-480
Open Access | Times Cited: 54
Allicin ameliorates aluminium- and copper-induced cognitive dysfunction in Wistar rats: relevance to neuro-inflammation, neurotransmitters and Aβ(1–42) analysis
Sunpreet Kaur, Khadga Raj, Y.K. Gupta, et al.
JBIC Journal of Biological Inorganic Chemistry (2021) Vol. 26, Iss. 4, pp. 495-510
Closed Access | Times Cited: 38
Navigating the GSK-3β inhibitors as versatile multi-target drug ligands in Alzheimer’s disease intervention – A comprehensive review
Nachiket Jitendra Joshi, Rajasekhar Reddy Alavala
Results in Chemistry (2024) Vol. 7, pp. 101500-101500
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top